Pseudocholinesterase, Dibucaine Inhibition
Pseudocholinesterase (butyrylcholinesterase, BCHE) is a serine hydrolase enzyme synthesized in the liver and present in plasma. It hydrolyzes ester-containing drugs such as succinylcholine and mivacurium, which are neuromuscular blocking agents used in anesthesia. Unlike acetylcholinesterase, which is concentrated at neuromuscular junctions, pseudocholinesterase is mainly in plasma and liver.
Deficiency of pseudocholinesterase, often due to inherited BCHE gene mutations, leads to increased sensitivity to choline ester muscle relaxants. Normally, neuromuscular function recovers within minutes after succinylcholine, but in affected individuals, paralysis and apnea may persist, requiring prolonged mechanical ventilation until drug clearance. Prevalence is estimated at 1 in 3,200–5,000 individuals. Acquired reductions occur in liver disease, malnutrition, chronic kidney disease, malignancy, and pregnancy. Conversely, elevated pseudocholinesterase activity is seen in obesity and chronic alcoholism.
Research also suggests a role in Alzheimer’s disease: increased plasma pseudocholinesterase may enhance the effect of ApoE4 in promoting cognitive decline, and higher enzyme levels have been associated with amyloid plaques and neurofibrillary tangles.
- As an aid the diagnosis of pseudocholinesterase deficiency
- Preoperative risk assessment before administration of succinylcholine or mivacurium
- As an aid in the diagnosis and prognosis of Alzheimer’s disease
Increased in:
- Alzheimer's disease with pathognomic features
- Chronic alcoholism
- Obesity
Decreased in:
- Liver disease (acute and chronic)
- Malnutrition and cachexia
- Pregnancy and estrogen therapy (e.g., hormonal contraceptives)
- Chronic kidney disease
- Malignancy
| Category | Age Range / Condition | Reference Range (U/L) |
|---|---|---|
| Male | All ages | 5,320 – 12,920 |
| Female | 0–15 years | 5,320 – 12,920 |
| 16–39 years | 4,260 – 11,250 | |
| 40–41 years | 5,320 – 12,920 | |
| ≥42 years | 5,320 – 12,920 | |
| 18–41 years (Pregnancy or hormonal contraceptive use) | 3,650 – 9,120 |
Serum, SST tube.
Stability
- Ambient: 24 hours
- Refrigerated: 5-7 days
- Frozen: 60 days
- AANA J. 2010 Aug;78(4):313-20. [PMID: 20879632]
- Am J Med Sci. 2019 Mar;357(3):263-267. [PMID: 30578021]
- Clin Chim Acta. 2015;450:34-45. [PMID: 25448037]
- Benner A, Lewallen NF, Sadiq NM. Biochemistry, Pseudocholinesterase. [Updated 2022 Sep 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545284